Literature DB >> 31424966

ARID1A knockdown triggers epithelial-mesenchymal transition and carcinogenesis features of renal cells: role in renal cell carcinoma.

Keerakarn Somsuan1, Paleerath Peerapen2, Wanida Boonmark2, Sirikanya Plumworasawat2, Ratirath Samol3, Natthiya Sakulsak1, Visith Thongboonkerd2.   

Abstract

Down-regulation/mutation of AT-rich interactive domain 1A (ARID1A), a novel tumor suppressor gene, has been reported in various cancers. Nevertheless, its role in renal cell carcinoma (RCC) remained unclear and underinvestigated. We thus evaluated carcinogenesis effects of ARID1A knockdown in nonmalignant Madin-Darby canine kidney (MDCK) renal cells using small interfering RNA (siRNA) against ARID1A (siARID1A). The siARID1A-transfected cells had decreased cell death, increased cell proliferation, and cell cycle shift (from G0/G1 to G2/M) compared with those transfected with controlled siRNA (siControl). Additionally, the siARID1A-transfected cells exhibited epithelial-mesenchymal transition (EMT) shown by greater spindle index, increased mesenchymal markers (fibronectin/vimentin), and decreased epithelial markers (E-cadherin/zonula occludens-1). Moreover, the siARID1A-transfected cells had increases in migratory activity, nuclear size, self-aggregated multicellular spheroid size, invasion capability, chemoresistance (to docetaxel), Snail family transcriptional repressor 1 expression, and TGF-β1 secretion. All of these siARID1A-knockdown effects on the carcinogenic features were reproducible in malignant RCC (786-O) cells, which exhibited a higher degree of carcinogenic phenotypes compared with the nonmalignant MDCK cells. Finally, immunohistochemistry showed obvious decrease in ARID1A protein expression in human RCC tissues (n = 23) compared with adjacent normal renal tissues (n = 23). These data indicate that ARID1A down-regulation triggers EMT and carcinogenesis features of renal cells in vitro, and its role in RCC could be proven in human tissues.-Somsuan, K., Peerapen, P., Boonmark, W., Plumworasawat, S., Samol, R., Sakulsak, N., Thongboonkerd, V. ARID1A knockdown triggers epithelial-mesenchymal transition and carcinogenesis features of renal cells: role in renal cell carcinoma.

Entities:  

Keywords:  EMT; cell cycle; chemoresistance; invasion; snail1

Mesh:

Substances:

Year:  2019        PMID: 31424966      PMCID: PMC6902729          DOI: 10.1096/fj.201802720RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  61 in total

1.  Programmed death ligand 1 promotes lymph node metastasis and glucose metabolism in cervical cancer by activating integrin β4/SNAI1/SIRT3 signaling pathway.

Authors:  Shaojia Wang; Jiajia Li; Jie Xie; Fei Liu; Yachen Duan; Yong Wu; Shenglin Huang; Xianghuo He; Ziliang Wang; Xiaohua Wu
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

2.  Role of HSP60 (HSPD1) in diabetes-induced renal tubular dysfunction: regulation of intracellular protein aggregation, ATP production, and oxidative stress.

Authors:  Siripat Aluksanasuwan; Kanyarat Sueksakit; Kedsarin Fong-Ngern; Visith Thongboonkerd
Journal:  FASEB J       Date:  2017-02-14       Impact factor: 5.191

3.  Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma.

Authors:  Yasunori Sato; Kenichi Harada; Keita Itatsu; Hiroko Ikeda; Yuko Kakuda; Syuji Shimomura; Xiang Shan Ren; Norihide Yoneda; Motoko Sasaki; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

4.  Prolonged K+ deficiency increases intracellular ATP, cell cycle arrest and cell death in renal tubular cells.

Authors:  Kedsarin Fong-Ngern; Nardtaya Ausakunpipat; Nilubon Singhto; Kanyarat Sueksakit; Visith Thongboonkerd
Journal:  Metabolism       Date:  2017-01-04       Impact factor: 8.694

5.  K+ deficiency caused defects in renal tubular cell proliferation, oxidative stress response, tissue repair and tight junction integrity, but enhanced energy production, proteasome function and cellular K+ uptake.

Authors:  Chompunoot Kapincharanon; Visith Thongboonkerd
Journal:  Cell Adh Migr       Date:  2017-09-14       Impact factor: 3.405

6.  Evaluation of the role of downregulation of SNF5/INI1 core subunit of SWI/SNF complex in clear cell renal cell carcinoma development.

Authors:  Elzbieta Sarnowska; Michal Szymanski; Nataliia Rusetska; Marcin Ligaj; Iga Jancewicz; Pawel Cwiek; Marta Skrodzka; Marcin Leszczynski; Joanna Szarkowska; Alicja Chrzan; Malgorzata Stachowiak; Jaroslaw Steciuk; Anna Maassen; Lech Galek; Tomasz Demkow; Janusz A Siedlecki; Tomasz J Sarnowski
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

7.  The role of components of the chromatin modification machinery in carcinogenesis of clear cell carcinoma of the ovary (Review).

Authors:  Hiroshi Shigetomi; Akira Oonogi; Taihei Tsunemi; Yasuhito Tanase; Yoshihiko Yamada; Hirotaka Kajihara; Yoriko Yoshizawa; Naoto Furukawa; Shoji Haruta; Shozo Yoshida; Toshiyuki Sado; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

8.  ARID1A, a SWI/SNF subunit, is critical to acinar cell homeostasis and regeneration and is a barrier to transformation and epithelial-mesenchymal transition in the pancreas.

Authors:  Wenjia Wang; Scott C Friedland; Bing Guo; Michael R O'Dell; William B Alexander; Christa L Whitney-Miller; Diana Agostini-Vulaj; Aaron R Huber; Jason R Myers; John M Ashton; Richard F Dunne; Laurie A Steiner; Aram F Hezel
Journal:  Gut       Date:  2018-09-18       Impact factor: 23.059

Review 9.  Non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in non-small cell lung cancer.

Authors:  Ying Chen; Lu Lu; Bing Feng; Siqi Han; Shiyun Cui; Xiaoyuan Chu; Longbang Chen; Rui Wang
Journal:  Oncotarget       Date:  2017-05-30

10.  Downregulation of ARID1A, a component of the SWI/SNF chromatin remodeling complex, in breast cancer.

Authors:  Chika Takao; Akemi Morikawa; Hiroshi Ohkubo; Yusuke Kito; Chiemi Saigo; Takuji Sakuratani; Manabu Futamura; Tamotsu Takeuchi; Kazuhiro Yoshida
Journal:  J Cancer       Date:  2017-01-01       Impact factor: 4.207

View more
  8 in total

1.  Persistent Escherichia coli infection in renal tubular cells enhances calcium oxalate crystal-cell adhesion by inducing ezrin translocation to apical membranes via Rho/ROCK pathway.

Authors:  Rattiyaporn Kanlaya; Visith Thongboonkerd
Journal:  Cell Mol Life Sci       Date:  2022-06-24       Impact factor: 9.261

2.  NPM-ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant Transformation.

Authors:  David L Cookmeyer; Damian Maseda; John K Everett; Jan M Pawlicki; Fang Wei; Hong Kong; Qian Zhang; Hong Y Wang; John W Tobias; David M Walter; Kelly M Zullo; Sarah Javaid; Amanda Watkins; Mariusz A Wasik; Frederic D Bushman; James L Riley
Journal:  Cancer Res       Date:  2021-02-22       Impact factor: 13.312

Review 3.  ARID1A serves as a receivable biomarker for the resistance to EGFR-TKIs in non-small cell lung cancer.

Authors:  Dantong Sun; Fei Teng; Puyuan Xing; Junling Li
Journal:  Mol Med       Date:  2021-10-29       Impact factor: 6.354

Review 4.  Nuclear Dynamics and Chromatin Structure: Implications for Pancreatic Cancer.

Authors:  Luis F Flores; Brooke R Tader; Ezequiel J Tolosa; Ashley N Sigafoos; David L Marks; Martin E Fernandez-Zapico
Journal:  Cells       Date:  2021-10-01       Impact factor: 6.600

5.  ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.

Authors:  Cristina Megino-Luque; Pol Sisó; Natalia Mota-Martorell; Raúl Navaridas; Inés de la Rosa; Izaskun Urdanibia; Manel Albertí-Valls; Maria Santacana; Miquel Pinyol; Núria Bonifaci; Anna Macià; David Llobet-Navas; Sònia Gatius; Xavier Matias-Guiu; Núria Eritja
Journal:  Mol Oncol       Date:  2022-03-02       Impact factor: 7.449

6.  Altered ARID1A expression in colorectal cancer.

Authors:  Mehran Erfani; Seyed Vahid Hosseini; Maral Mokhtari; Mozhdeh Zamani; Kamran Tahmasebi; Mahvash Alizadeh Naini; Alireza Taghavi; John M Carethers; Minoru Koi; Hassan Brim; Pooneh Mokarram; Hassan Ashktorab
Journal:  BMC Cancer       Date:  2020-04-25       Impact factor: 4.430

7.  Role of ARID1A in epithelial‑mesenchymal transition in breast cancer and its effect on cell sensitivity to 5‑FU.

Authors:  Tangshun Wang; Xiang Gao; Kexin Zhou; Tao Jiang; Shuang Gao; Pengzhou Liu; Ximeng Zuo; Xiaoguang Shi
Journal:  Int J Mol Med       Date:  2020-09-15       Impact factor: 4.101

8.  ARID1A knockdown enhances carcinogenesis features and aggressiveness of Caco-2 colon cancer cells: An in vitro cellular mechanism study.

Authors:  Paleerath Peerapen; Kanyarat Sueksakit; Wanida Boonmark; Sunisa Yoodee; Visith Thongboonkerd
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.